Detalhe da pesquisa
1.
The impact of indoor pollution on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.
Allergy
; 2024 Feb 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366695
2.
The impact of outdoor pollution and extreme temperatures on asthma-related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma.
Allergy
; 2024 Feb 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38311978
3.
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison.
Regul Toxicol Pharmacol
; 144: 105485, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37659711
4.
Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital. / Caracterización de los eventos adversos a hidroxicloroquina, ivermectina, azitromicina y tocilizumab en pacientes hospitalizados por la COVID-19 en un hospital del Seguro Social de Salud del Perú.
Rev Peru Med Exp Salud Publica
; 40(1): 16-24, 2023.
Artigo
em Espanhol, Inglês
| MEDLINE | ID: mdl-37377231
5.
Drug utilization research in Peru: Is real-world data available?
Front Pharmacol
; 13: 1047946, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733379
6.
Knowledge, attitudes and practices of pharmacovigilance in the context of COVID-19 in health professionals of the peruvian social insurance. / Conocimientos, actitudes y prácticas de farmacovigilancia en el contexto de la COVID-19 en profesionales de la salud del Seguro Social del Perú.
Rev Peru Med Exp Salud Publica
; 39(1): 91-97, 2022.
Artigo
em Espanhol, Inglês
| MEDLINE | ID: mdl-35766746
7.
Contenido de sodio en antimicrobianos parenterales: Una fuente extra de sodio a considerarse en pacientes hospitalizados
Rev. chil. infectol
; 40(1)feb. 2023.
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1441401
8.
Trombocitopenia severa inducida por un oclusor para DAP: reporte de caso en tecnovigilancia
Rev. Cuerpo Méd. Hosp. Nac. Almanzor Aguinaga Asenjo
; 16(1)ene. 2023.
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1535140
9.
Caracterización de eventos adversos a hidroxicloroquina, ivermectina, azitromicina y tocilizumab en pacientes hospitalizados por COVID-19 en un hospital del Seguro Social de Salud del Perú / Characterization of adverse events to hydroxychloroquine, ivermectin, azithromycin and tocilizumab in patients hospitalized due to COVID-19 in a Peruvian Social Health Insurance hospital
Rev. peru. med. exp. salud publica
; 40(1): 16-24, ene. 2023. tab, graf
Artigo
em Espanhol
| LILACS | ID: biblio-1442115
10.
Conocimientos, actitudes y prácticas de farmacovigilancia en el contexto de la COVID-19 en profesionales de la salud del Seguro Social del Perú / Knowledge, attitudes and practices of pharmacovigilance in the context of COVID-19 in health professionals of the peruvian social insurance
Rev. peru. med. exp. salud publica
; 39(1): 91-97, ene.-mar. 2022. tab, graf
Artigo
em Espanhol
| LILACS | ID: biblio-1389933
11.
Cardiotoxicidad asociado al uso de carmustina: Reporte de caso en farmacovigilancia / Carmustine-induced cardiotoxicity: A pharmacovigilance case report
Rev. Cuerpo Méd. Hosp. Nac. Almanzor Aguinaga Asenjo
; 14(4): 595-598, Dic. 29, 2021.
Artigo
em Espanhol
|
LILACS-Express
| ID: biblio-1367800